What if you'd held XTLB?
A $1,000 investment in XTL Biopharmaceuticals Ltd. (XTLB) at the month-end close of 2005-09 would be worth $1.31 at the close of 2026-09 — -99.9% total return, dividends reinvested. The same $1,000 in the S&P 500, dividends reinvested, would be worth $9,354.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-09, dividends included.
Every year, $1,000 from 2005
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2005 | $1,000 | — |
| 2006 | $354 | -64.6% |
| 2007 | $368 | +4.0% |
| 2008 | $6.46 | -98.2% |
| 2009 | $12.92 | +100.0% |
| 2010 | $60.72 | +370.0% |
| 2011 | $49.10 | -19.1% |
| 2012 | $95.87 | +95.3% |
| 2013 | $37.47 | -60.9% |
| 2014 | $25.58 | -31.7% |
| 2015 | $18.22 | -28.8% |
| 2016 | $8.14 | -55.3% |
| 2017 | $5.92 | -27.3% |
| 2018 | $4.47 | -24.5% |
| 2019 | $3.54 | -20.8% |
| 2020 | $7.83 | +121.2% |
| 2021 | $7.16 | -8.6% |
| 2022 | $3.13 | -56.3% |
| 2023 | $2.61 | -16.5% |
| 2024 | $5.25 | +101.0% |
| 2025 | $1.50 | -71.4% |
| 2026 | $1.63 | +9.1% |
Best and worst month-end to buy
The best single month-end close to have bought XTLB was 2025-12 ($2.32): $1,000 then is $1,091 today. The worst was 2005-09 ($1,928): $1,000 then is $1.31.
FAQ
What would $1,000 in XTLB be worth today?
A $1,000 investment in XTL Biopharmaceuticals Ltd. (XTLB) at the start of 2005 would be worth about $1.31 today, a total return of -99.9%. Dividends are reinvested in these figures.
What were the best and worst years for XTLB?
XTL Biopharmaceuticals Ltd. (XTLB)'s strongest calendar year since 2005 was 2010, a +370.0% return — $1,000 held through that year became about $4,700 by year-end. Its weakest year was 2008, at -98.2%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in XTLB have grown?
Investing $100 at the end of every month since 2005-09 would have grown to about $5,585 on $25,300 invested.
Did XTLB beat the S&P 500?
Over the same period, $1,000 in the S&P 500 with dividends reinvested (the S&P 500 Total Return index) would be worth $9,354. XTLB trailed the S&P 500 by +100.0% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
XTL Biopharmaceuticals Ltd. (XTLB) historical total-return data from 2005-09 to 2026-09, reduced to month-end closes for the tables above.
Returns use adjusted close prices — adjusted for stock splits and reinvested dividends, the same convention used by major brokerages. End-of-day and live prices come from EODHD; parts of the deep historical series are carried over from Yahoo Finance data. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (EODHD): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via EODHD and Yahoo Finance. As of 2026-09-04. Not financial advice.